Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 963507, 11 pages
http://dx.doi.org/10.1155/2014/963507
Research Article

Human Serum Albumin Conjugates of 7-Ethyl-10-hydroxycamptothecin (SN38) for Cancer Treatment

1Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14155-6451, Tehran, Iran
2Nanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14155-6451, Tehran, Iran
3Nano Alvand Co., Avicenna Tech. Park, Tehran University of Medical Sciences, Tehran, Iran
4Department of Toxicology-Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
5Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Received 7 February 2014; Revised 28 March 2014; Accepted 10 April 2014; Published 7 May 2014

Academic Editor: Mehrdad Hamidi

Copyright © 2014 Nima Sepehri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Nima Sepehri, Hasti Rouhani, Ahmad Reza Ghanbarpour, et al., “Human Serum Albumin Conjugates of 7-Ethyl-10-hydroxycamptothecin (SN38) for Cancer Treatment,” BioMed Research International, vol. 2014, Article ID 963507, 11 pages, 2014. doi:10.1155/2014/963507